Epimestrol

Legal Information Eppendorf is a registered trademark of Eppendorf AG MixMate is a registered trademark of Eppendorf AG

Upgrade set 2-position slider for epMotion® 96

UT-155 is a selective and potent androgen receptor (AR) antagonist, with a K i of 267 nM for UT-155 binding to AR-LBD.In VitroUT-155 binds to the AR-LBD at K i of 267 nM. UT-155 potently inhibits the R1881-induced wildtype AR transactivation with

UT-155 is a selective and potent androgen receptor (AR) antagonist, with a K i of 267 nM for UT-155 binding to AR-LBD.In VitroUT-155 binds to the AR-LBD at K i of 267 nM. UT-155 potently inhibits the R1881-induced wildtype AR transactivation with

UT-155 is a selective and potent androgen receptor (AR) antagonist, with a K i of 267 nM for UT-155 binding to AR-LBD.In VitroUT-155 binds to the AR-LBD at K i of 267 nM. UT-155 potently inhibits the R1881-induced wildtype AR transactivation with

UT-155 is a selective and potent androgen receptor (AR) antagonist, with a K i of 267 nM for UT-155 binding to AR-LBD.In VitroUT-155 binds to the AR-LBD at K i of 267 nM. UT-155 potently inhibits the R1881-induced wildtype AR transactivation with

UT-155 is a selective and potent androgen receptor (AR) antagonist, with a K i of 267 nM for UT-155 binding to AR-LBD.In VitroUT-155 binds to the AR-LBD at K i of 267 nM. UT-155 potently inhibits the R1881-induced wildtype AR transactivation with

UT-155 is a selective and potent androgen receptor (AR) antagonist, with a K i of 267 nM for UT-155 binding to AR-LBD.In VitroUT-155 binds to the AR-LBD at K i of 267 nM. UT-155 potently inhibits the R1881-induced wildtype AR transactivation with